Skip to main content
logo
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
10.09
+0.01 (0.10%)
At close: Aug 14, 2026, 4:00 PM EDT
10.29
+0.20 (1.98%)
After-hours: Aug 14, 2026, 7:59 PM EDT

CRBP Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.88
Revenue Growth
------77.61%
Gross Profit
-90.26-70.1-32.22-31.17-16.14-35.56
Operating Income
-106.88-85.31-48.72-45.08-34.84-55.99
Net Income
-101.9-78.54-40.21-44.6-42.35-45.64
Earnings Per Share
-6.09-5.90-3.68-10.31-10.15-11.15
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
117.94163.27149.0620.9159.297.65
Total Debt
4.261.633.2420.8925.0926.59
Net Cash (Debt)
113.68161.64145.820.0234.1171.06
Net Cash Growth
-0.40%10.84%694295.24%-99.94%-52.00%21.26%
Net Cash Per Share
6.7912.1413.360.008.1817.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-86.67-64.49-41.79-36.1-37.54-48.18
Capital Expenditures
-0.02-0.01---0.01-0.05
Free Cash Flow
-86.69-64.5-41.79-36.1-37.56-48.24
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------6350.09%
Pretax Margin
------5176.38%
Profit Margin
------5176.38%
FCF Margin
------5470.98%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----87.45